摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,2,3',4'-Tetra-O-acetyl-2',5,6'-tri-O-benzyl-3-O-α-D-glucopyranosyl-D-ribofuranose | 197644-83-0

中文名称
——
中文别名
——
英文名称
1,2,3',4'-Tetra-O-acetyl-2',5,6'-tri-O-benzyl-3-O-α-D-glucopyranosyl-D-ribofuranose
英文别名
Bn(-2)[Bn(-6)]Glc3Ac4Ac(a1-3)[Bn(-5)]Ribf1Ac2Ac;[(2R,3R,4S,5R,6R)-4-acetyloxy-6-[(2R,3R,4R)-4,5-diacetyloxy-2-(phenylmethoxymethyl)oxolan-3-yl]oxy-5-phenylmethoxy-2-(phenylmethoxymethyl)oxan-3-yl] acetate
1,2,3',4'-Tetra-O-acetyl-2',5,6'-tri-O-benzyl-3-O-α-D-glucopyranosyl-D-ribofuranose化学式
CAS
197644-83-0
化学式
C40H46O14
mdl
——
分子量
750.797
InChiKey
LUZLRRGQJGCXOG-JNGFPJBTSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    779.4±60.0 °C(Predicted)
  • 密度:
    1.29±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    54
  • 可旋转键数:
    21
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    161
  • 氢给体数:
    0
  • 氢受体数:
    14

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    参考文献:
    名称:
    使用碱基置换策略研究腺嘌呤碱基对腺苷A活性的贡献。
    摘要:
    3'-O-α-D-吡喃葡萄糖基-1-β-D-呋喃呋喃糖基氨基咪唑2',3'',4''-三磷酸(7)和3'-O-α-D-吡喃葡萄糖基-9-beta的合成描述了-D-呋喃呋喃核糖嘌呤2',3'',4''-三磷酸(8),这是超强1D-肌醇1,4,5-三磷酸受体激动剂腺苷A(2)的两个类似物。通过改进的路线由1,2-O-异亚丙基-α-D-木呋喃糖制备5-O-苄基-1,2-O-异亚丙基-α-D-呋喃核糖,并与3,4-di-O偶联-乙酰基-2,6-二-O-苄基-D-吡喃葡萄糖基二甲基亚磷酸酯得到3',4'-二-O-乙酰基-2',5,6'-三-O-苄基-3-O- α-D-吡喃葡萄糖基-1,2-O-异亚丙基-α-D-呋喃呋喃糖。除去异亚丙基缩醛并随后乙酰化得到中心二糖1,2,3',4'-四-O-乙酰基-2',5、6'-三-O-苄基-3-O-α-D-吡喃葡萄糖基-D-呋喃呋喃糖。用活化的咪唑或嘌呤进行弗布吕
    DOI:
    10.1021/jm000265o
  • 作为产物:
    参考文献:
    名称:
    Synthesis of Potent Agonists of the d-myo-Inositol 1,4,5-Trisphosphate Receptor Based on Clustered Disaccharide Polyphosphate Analogues of Adenophostin A
    摘要:
    Clustered disaccharide analogues of adenophostin A (2), i.e. mono-, di-, and tetravalent derivatives 6-8, respectively, were synthesized and evaluated as novel ligands for the tetrameric D-myo-inositol 1,4,5-trisphosphate receptor (IP3R). The synthesis was accomplished via Sonogashira coupling of propargyl 2-O-acetyl-5-O-benzyl-3-O-(3,4-di-O-acetyl-2,6-di-O-benzyl-alpha-D-glucopyranosyl)-beta-D-ribofuranoside (16) with iodobenzene 18, 22, or 25, followed by deacetylation, phosphorylation, and deprotection. The abilities of the target compounds 6-8, as well as ribophostin 4, propylphostin 5, and IP3 (1), to evoke Ca2+ release from permeabilized hepatocytes or displacement of [H-3]IP3 from its receptor in hepatic membranes were compared. Although the binding affinities of 4-8 were similar, there were modest though significant differences in their potencies in Ca2+ release assays: tetraphostin 8 > IP3 similar to diphostin 7 > phenylphostin 6 > ribophostin 4 similar to propylphostin 5.
    DOI:
    10.1021/jm000957c
点击查看最新优质反应信息

文献信息

  • Triazolophostins: a library of novel and potent agonists of IP<sub>3</sub>receptors
    作者:Amol M. Vibhute、Vera Konieczny、Colin W. Taylor、Kana M. Sureshan
    DOI:10.1039/c5ob00440c
    日期:——

    IP3R initiate most cellular Ca2+signaling. AdA is the most potent agonist of IP3R. The structural complexity of AdA makes synthesis of its analogs cumbersome. We report an easy method for generating a library of potent triazole-based analogs of AdA, triazolophostins, which are the most potent AdA analogs devoid of a nucleobase.

    IP3R启动大多数细胞Ca2+信号传导。AdA是IP3R最有效的激动剂。AdA的结构复杂性使其类似物的合成繁琐。我们报告了一种简单的方法,用于生成一系列强效的基于三唑的AdA类似物库,即三唑磷,它们是最强效的AdA类似物,不含核碱基。
  • Convergent synthesis of adenophostin A analogues via a base replacement strategy
    作者:Rachel D. Marwood、Satoshi Shuto、David J. Jenkins、Barry V. L. Potter
    DOI:10.1039/a909347h
    日期:——
    The first totally synthetic base-modified analogues of the natural product and potent D-myo-inositol 1,4,5-trisphosphate receptor agonist adenophostin A were efficiently synthesised from D-xylose and D-glucose using methodology employing base and surrogate base addition to a common disaccharide intermediate.
    天然产物的第一个完全合成的碱基修饰类似物和有效的 D-肌醇 1,4,5-三磷酸受体激动剂腺苷 A 是由 D-木糖D-葡萄糖使用碱基和替代碱基添加的方法有效合成的一种常见的二糖中间体
  • Synthesis of Clustered Disaccharide Polyphosphate Analogues of Adenophostin A
    作者:Martin de Kort、A.Rob P.M. Valentijn、Gijs A. van der Marel、Jacques H. van Boom
    DOI:10.1016/s0040-4039(97)01811-x
    日期:1997.10
    Three new potential ligands for the IP3 receptor (i.e. compounds 5–7) were prepared by Sonogashira coupling of propargyl 2-O-acetyl-5-O-benzyl-3-O-(3,4-di-O-acetyl-2,6-di-O-benzyl-α-d- glycopyranosyl)-β-d-ribofuranoside (15) with iodobenzene, 1,2-diiodobenzene and 1,2,4,5-tetraiodobenzene, followed by deacetylation, phosphorylation and deprotection. © 1997 Elsevier Science Ltd.
    通过炔丙基2 - O-乙酰基-5- O-苄基-3- O-(3,4-二-O-乙酰基- )的Sonogashira偶联,制备了IP 3受体的三个新的潜在配体(即化合物5-7)。2,6-二-O-苄基-α-d-葡萄糖基)-β-d-呋喃核糖苷(15)与碘苯1,2-二碘苯1,2,4,5-四碘苯,然后进行乙酰基化,磷酸化和保护。©1997爱思唯尔科学有限公司。
  • Guanophostin A: Synthesis and evaluation of a high affinity agonist of the d-myo-inositol 1,4,5-trisphosphate receptor
    作者:Kana M. Sureshan、Melanie Trusselle、Stephen C. Tovey、Colin W. Taylor、Barry V. L. Potter
    DOI:10.1039/b517911d
    日期:——
    Guanophostin A, the guanosine counterpart of the inositol 1,4,5-trisphosphate receptor agonist adenophostin A, has been synthesized and is the first synthetic adenophostin A-like analogue to be equipotent to its parent in stimulating intracellular Ca2+ release; its nucleotide moiety is proposed to interact with the receptor binding core by guanine base cation-π stacking with Arg504 and hydrogen bonding with Glu505 and interaction of the ribosyl 2′-phosphate group with the helix-dipole of α6.
    Guanophostin A 是 1,4,5-三磷酸肌醇受体激动剂腺苷 A 的鸟苷对应物,已被合成,它是第一个在刺激细胞内 Ca2+ 释放方面与其母体等效的合成腺苷 A 类似物;据推测,其核苷酸分子通过鸟嘌呤基阳离子-π堆叠与 Arg504、键与 Glu505 以及核糖基 2′-磷酸基团与 α6 的螺旋偶极相互作用,与受体结合核心相互作用。
  • Total Synthesis of Nucleobase-Modified Adenophostin A Mimics
    作者:Satoshi Shuto、Graeme Horne、Rachel D. Marwood、Barry V. L. Potter
    DOI:10.1002/1521-3765(20011119)7:22<4937::aid-chem4937>3.0.co;2-g
    日期:2001.11.19
    The adenophostins exhibit approximately 10-100 times higher receptor binding and Ca2+ mobilising potencies in comparison with the natural second messenger D-myo-inositol 1,4,5-trisphosphate [Ins(1,4,5)P-3]. Despite many synthetic attempts to determine the minimal structural requirement for this unusual behaviour of the adenophostins, few related simplified analogues displaying higher activity than that of Ins(1.4,5)P-3 have been reported. However, biological evaluation of such analogues has revealed that one of the key factors for the enhanced biological activity is the adenine moiety. To further understand the effect that the adenine base has upon the activity of the adenophostins, congeners in which this functionality is replaced by uracil, benzimidazole, 2-methoxynaphthalene, 4-methylanisole and 4-methylnaphthalene using the common intermediate 1,2-di-O-acetyl-5-O-benzyl-3-O-(3,4-di-O-acetyl-2,6-di-O-benzyl-alpha -D-glucopyranosyl)-ribofuranose have been synthesised using a base replacement strategy. The synthesis of the uracil and benzimidazole analogues was achieved using the Vorbruggen condensation procedure. The 1'-C-glycosidic analogues were prepared using Friedel-Crafts type C-aryl glycosidation reactions. Phosphate groups were introduced using the phosphoramidite method with subsequent removal of all-benzyl protecting groups by catalytic hydrogenation or catalytic hydrogen transfer. Apart from one analogue with an alpha -glycosidic linkage all compounds were more potent than Ins(1,4,5)P-3 and most tended more towards adenophostin in activity. These analogues will be valuable tools to unravel the role that the adenine moiety plays in the potent activity of the adenophostins and demonstrate that this strategy is effective at producing highly potent ligands.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸